SLC5A2 and bacterial urinary tract infection: A larger retrospective population-based study conducted in Canada showed that SGLT-2 inhibitors were not statistically associated with increased risk of UTI and that the history of UTI in the last 60 days did not increase the rate of UTI in patients using SGLT-2 inhibitors [57].